Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP300252.RAamrbe_RPqe1DfbSwzvC5FZ5HgPgC2Q5jLcScjbC70gk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP300252.RAamrbe_RPqe1DfbSwzvC5FZ5HgPgC2Q5jLcScjbC70gk130_assertion type Assertion NP300252.RAamrbe_RPqe1DfbSwzvC5FZ5HgPgC2Q5jLcScjbC70gk130_head.
- NP300252.RAamrbe_RPqe1DfbSwzvC5FZ5HgPgC2Q5jLcScjbC70gk130_assertion description "[The discovery of JAK2 and MPL mutations in patients with myeloproliferative neoplasms (MPNs) provided important insight into the genetic basis of these disorders and led to the development of JAK2 kinase inhibitors for MPN therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP300252.RAamrbe_RPqe1DfbSwzvC5FZ5HgPgC2Q5jLcScjbC70gk130_provenance.
- NP300252.RAamrbe_RPqe1DfbSwzvC5FZ5HgPgC2Q5jLcScjbC70gk130_assertion evidence source_evidence_literature NP300252.RAamrbe_RPqe1DfbSwzvC5FZ5HgPgC2Q5jLcScjbC70gk130_provenance.
- NP300252.RAamrbe_RPqe1DfbSwzvC5FZ5HgPgC2Q5jLcScjbC70gk130_assertion SIO_000772 20154217 NP300252.RAamrbe_RPqe1DfbSwzvC5FZ5HgPgC2Q5jLcScjbC70gk130_provenance.
- NP300252.RAamrbe_RPqe1DfbSwzvC5FZ5HgPgC2Q5jLcScjbC70gk130_assertion wasDerivedFrom befree-20140225 NP300252.RAamrbe_RPqe1DfbSwzvC5FZ5HgPgC2Q5jLcScjbC70gk130_provenance.
- NP300252.RAamrbe_RPqe1DfbSwzvC5FZ5HgPgC2Q5jLcScjbC70gk130_assertion wasGeneratedBy ECO_0000203 NP300252.RAamrbe_RPqe1DfbSwzvC5FZ5HgPgC2Q5jLcScjbC70gk130_provenance.